San Antonio Texas Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center

• Category: Corporations - Public - Licenses
• State: Multi-State
• City: San Antonio
• Control #: US-EG-9161
• Format: Word; Rich Text

Description

Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages A San Antonio Texas Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legal agreement that outlines the terms and conditions regarding intellectual property rights and licensing of technology or inventions developed by either party. This agreement aims to protect the interests of Gentling, Inc. and The University of North Texas Health Science Center while facilitating the commercialization and utilization of research and innovation. The Collateral License Agreement typically covers a range of important aspects, including: 1. Definitions and Background: This section defines key terms and provides a background of the collaborative efforts between Gentling, Inc. and The University of North Texas Health Science Center leading to the need for this agreement. 2. Grant of Licenses: This clause grants Gentling, Inc. a non-exclusive, worldwide, royalty-bearing license to the intellectual property developed by The University of North Texas Health Science Center. It outlines the scope of the license and any limitations or restrictions on its use. 3. Intellectual Property Ownership: This section clarifies the ownership of intellectual property created during the partnership. It typically establishes that The University of North Texas Health Science Center retains ownership but grants a license to Gentling, Inc. for specific uses. 4. Commercialization and Royalties: This clause outlines the responsibilities and obligations of both parties regarding the commercialization and marketing of the licensed technology or invention. It may also discuss the payment of royalties, milestones, and sublicensing arrangements. 5. Patent Prosecution and Maintenance: This section defines the roles and responsibilities of each party regarding filing, prosecuting, and maintaining any patents related to the licensed intellectual property. 6. Confidentiality: This clause ensures the protection of proprietary and confidential information shared between Gentling, Inc. and The University of North Texas Health Science Center during the collaborative research process. 7. Indemnification: This section outlines the liability and indemnification obligations of each party in case of any claims or disputes arising from the use or infringement of the licensed intellectual property. 8. Term and Termination: This clause specifies the duration of the agreement and the conditions under which either party may terminate it, including breach of terms or failure to meet certain obligations. Types of collateral license agreements between Gentling, Inc. and The University of North Texas Health Science Center may vary based on the specific technologies or inventions being licensed and the intended use. Some potential types of agreements may include Collateral License Agreement for a specific gene therapy technology, Collateral License Agreement for a diagnostic test, or Collateral License Agreement for a medical device. Keywords: San Antonio Texas, Collateral License Agreement, Gentling, Inc., The University of North Texas Health Science Center, intellectual property, licensing, commercialization, royalties, patent prosecution, confidential information, indemnification, termination.

A San Antonio Texas Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legal agreement that outlines the terms and conditions regarding intellectual property rights and licensing of technology or inventions developed by either party. This agreement aims to protect the interests of Gentling, Inc. and The University of North Texas Health Science Center while facilitating the commercialization and utilization of research and innovation. The Collateral License Agreement typically covers a range of important aspects, including: 1. Definitions and Background: This section defines key terms and provides a background of the collaborative efforts between Gentling, Inc. and The University of North Texas Health Science Center leading to the need for this agreement. 2. Grant of Licenses: This clause grants Gentling, Inc. a non-exclusive, worldwide, royalty-bearing license to the intellectual property developed by The University of North Texas Health Science Center. It outlines the scope of the license and any limitations or restrictions on its use. 3. Intellectual Property Ownership: This section clarifies the ownership of intellectual property created during the partnership. It typically establishes that The University of North Texas Health Science Center retains ownership but grants a license to Gentling, Inc. for specific uses. 4. Commercialization and Royalties: This clause outlines the responsibilities and obligations of both parties regarding the commercialization and marketing of the licensed technology or invention. It may also discuss the payment of royalties, milestones, and sublicensing arrangements. 5. Patent Prosecution and Maintenance: This section defines the roles and responsibilities of each party regarding filing, prosecuting, and maintaining any patents related to the licensed intellectual property. 6. Confidentiality: This clause ensures the protection of proprietary and confidential information shared between Gentling, Inc. and The University of North Texas Health Science Center during the collaborative research process. 7. Indemnification: This section outlines the liability and indemnification obligations of each party in case of any claims or disputes arising from the use or infringement of the licensed intellectual property. 8. Term and Termination: This clause specifies the duration of the agreement and the conditions under which either party may terminate it, including breach of terms or failure to meet certain obligations. Types of collateral license agreements between Gentling, Inc. and The University of North Texas Health Science Center may vary based on the specific technologies or inventions being licensed and the intended use. Some potential types of agreements may include Collateral License Agreement for a specific gene therapy technology, Collateral License Agreement for a diagnostic test, or Collateral License Agreement for a medical device. Keywords: San Antonio Texas, Collateral License Agreement, Gentling, Inc., The University of North Texas Health Science Center, intellectual property, licensing, commercialization, royalties, patent prosecution, confidential information, indemnification, termination.